First Republic Investment Management Inc. grew its stake in Zoetis Inc (NYSE:ZTS) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,325 shares of the company’s stock after purchasing an additional 1,078 shares during the quarter. First Republic Investment Management Inc.’s holdings in Zoetis were worth $1,487,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Wilbanks Smith & Thomas Asset Management LLC increased its position in Zoetis by 1.8% in the second quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 5,682 shares of the company’s stock worth $354,000 after buying an additional 98 shares during the last quarter. Scotia Capital Inc. increased its position in Zoetis by 1.5% in the second quarter. Scotia Capital Inc. now owns 9,628 shares of the company’s stock worth $601,000 after buying an additional 142 shares during the last quarter. Nordea Investment Management AB increased its position in Zoetis by 0.7% in the second quarter. Nordea Investment Management AB now owns 24,854 shares of the company’s stock worth $1,550,000 after buying an additional 169 shares during the last quarter. Moors & Cabot Inc. increased its position in Zoetis by 1.1% in the second quarter. Moors & Cabot Inc. now owns 14,969 shares of the company’s stock worth $929,000 after buying an additional 170 shares during the last quarter. Finally, Bronfman E.L. Rothschild L.P. increased its position in Zoetis by 8.5% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 2,789 shares of the company’s stock worth $174,000 after buying an additional 219 shares during the last quarter. Institutional investors own 93.33% of the company’s stock.

A number of analysts have issued reports on ZTS shares. BMO Capital Markets reissued a “hold” rating and issued a $65.00 target price on shares of Zoetis in a research report on Thursday, November 2nd. Cowen set a $80.00 target price on Zoetis and gave the stock a “buy” rating in a research report on Friday, November 17th. Morgan Stanley raised Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research report on Wednesday, November 29th. Stifel Nicolaus reissued a “buy” rating and issued a $65.00 target price on shares of Zoetis in a research report on Friday, September 1st. Finally, UBS reissued a “neutral” rating on shares of Zoetis in a research report on Friday, November 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company. Zoetis currently has an average rating of “Buy” and an average price target of $68.53.

Zoetis Inc (ZTS) traded up $0.15 during trading on Thursday, hitting $72.38. The stock had a trading volume of 1,595,000 shares, compared to its average volume of 2,752,414. Zoetis Inc has a 52-week low of $50.57 and a 52-week high of $72.99. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45. The company has a market capitalization of $35,270.00, a price-to-earnings ratio of 33.13, a P/E/G ratio of 2.17 and a beta of 1.06.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same period last year, the company earned $0.52 earnings per share. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. research analysts forecast that Zoetis Inc will post 2.37 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be paid a dividend of $0.126 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date is Thursday, January 18th. This represents a $0.50 annualized dividend and a yield of 0.70%. Zoetis’s dividend payout ratio (DPR) is currently 22.11%.

COPYRIGHT VIOLATION NOTICE: “First Republic Investment Management Inc. Purchases 1,078 Shares of Zoetis Inc (ZTS)” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.dailypolitical.com/2017/12/14/first-republic-investment-management-inc-purchases-1078-shares-of-zoetis-inc-zts.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.